{
    "url_original": "https://www.wsj.com/articles/johnson-johnson-mcdonalds-toyota-stocks-that-defined-the-week-11639786757?mod=markets_lead_pos11",
    "url": "johnson-johnson-mcdonalds-toyota-stocks-that-defined-the-week-11639786757",
    "title": "Johnson & Johnson, McDonald’s, Toyota: Stocks That Defined the Week",
    "sub_head": "Here are seven major companies whose stocks moved on the week’s news",
    "category_1": "Markets",
    "category_2": "Stocks",
    "image_1_url": "https://images.wsj.net/im-454870?width=860&height=573",
    "image_1": "im-454870.jpg",
    "time": "2021-12-17 19:19:00",
    "body": "U.S. vaccine advisers recommended adults take a Covid-19 vaccine from  Pfizer Inc.  or  Moderna Inc.  over J&J’s after health authorities said the rate of a rare but serious blood-clotting condition was higher than previously detected. The updated position is likely to deal another blow to use of the J&J shot, whose uptake had been hurt by manufacturing issues and earlier reports of the blood-clotting condition. J&J shares closed nearly 2.8% lower Friday.<br />The line between beer and soda is about to get blurrier. Anheuser-Busch said Thursday that it is introducing a line of Bud Light-branded hard soda in cola, cherry cola, orange and lemon-lime flavors.  PepsiCo Inc.  early next year will also roll out an alcoholic version of Mountain Dew in a partnership with  Boston Beer Co."
}